Table 2.
Distribution of iNOS scores of tumor cells (iNOS-T), tumor-associated stromal fibroblasts (iNOS-F), and endothelial cells (iNOS-E) according to clinicopathologic parameters in cases with gastric carcinoma
| Variables |
iNOS Score [Mean ± SD (Min.-Max.)] |
||
|---|---|---|---|
| iNOS-T | iNOS-F | iNOS-E | |
|
Histological type | |||
| NOS/tubular/papillary |
2.6 ± 2.3 (0–6) |
4.8 ± 1.7 (2–8) |
5.9 ± 2.1 (2–8) |
| Mucinous/poorly cohesive |
4.8 ± 2.2 (2–8) |
4.4 ± 1.9 (2–7) |
5.9 ± 2.7 (2–8) |
|
Differentiation | |||
| Well/moderate |
2.6 ± 2.3 (0–6) |
4.6 ± 2.2 (0–8) |
5.6 ± 2.8 (2–8) |
| Poorly/signet ring cell |
4.8 ± 2.2 (2–8) |
4.3 ± 1.3 (0–8) |
6.0 ± 1.6 (2–8) |
|
pN | |||
|
N0 |
1.3 ± 1.8 (0–5) |
2.9 ± 1.3 (2–5) |
3.2 ± 1.9 (2–7) |
| N1 |
4.1 ± 1.3 (2–6) |
5.9 ± 1.6 (4–8) |
6.7 ± 1.7 (4–8) |
| N2 |
4.1 ± 1.9 (2–8) |
4.9 ± 1.2 (3–7) |
6.6 ± 1.3 (4–8) |
| N3 |
5.9 ± 2.2 (2–8) |
5.2 ± 1.2 (3–7) |
6.6 ± 1.1 (4–8) |
|
pT | |||
| T1 |
1.5 ± 1.1 (0–7) |
2.4 ± 1.2 (2–7) |
3.1 ± 1.7 (2–7) |
| T2 |
4.2 ± 1.5 (2–6) |
5.4 ± 1.7 (4–8) |
6.8 ± 1.8 (4–8) |
| T3 |
4.4 ± 1.9 (2–8) |
4.9 ± 1.5 (3–7) |
6.2 ± 1.7 (4–8) |
| T4 |
5.9 ± 2.1 (2–8) |
5.1 ± 1.4 (3–7) |
6.9 ± 1.2 (4–8) |
|
TNM stage | |||
| I |
0.0 ± 0.0 (0–0) |
3.3 ± 1.5 (2–5) |
4.0 ± 2.6 (2–7) |
| II |
3.2 ± 1.8 (0–6) |
4.4 ± 1.9 (2–8) |
5.0 ± 2.4 (2–8) |
| III |
5.4 ± 3.2 (2–8) |
5.3 ± 1.3 (3–7) |
6.8 ± 1.0 (4–8) |
| IV |
- |
- |
- |
| Total | 4.0 ± 2.5 (0–8) | 4.0 ± 2.5 (0–8) | 5.9 ± 2.0 (2–8) |